Clinical TrialsSearch results
Number of results: 68599
Completed
- A Phase 2, Multicenter, Global, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Cendakimab (CC-93538) in Adult Subjects with Moderate to Severe Atopic Dermatitis.
- Moderate to severe Atopic dermatitis (AD)
- Changliang Zhang
- 2021-05-25
Completed
- A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19
- COVID-19
- Hibi Kazushige
- 2024-03-28
Completed
- A Phase 2, Randomized, Double-Blind, does-finding, Parallel Group, Multi-Center Study to evaluate Efficacy and Safety of M118103 in Subjects with Prurigo nodularis.
- Prurigo nodularis
- Nishiura Tomoyuki
- 2021-04-09
Completed
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate REduction in Inflammation in PatientS With Advanced Chronic Renal Disease Utilizing Antibody-MEdiated Interleukin-6 Inhibition in Japan (NN6018-4776)
- Chronic kidney disease
- Kanmuri Kazuhiro
- 2020-11-25
Completed
- A phase 2, randomized, placebo-controlled, double-blind, dose-finding study of TS-172 in hyperphosphatemia patients on hemodialysis
- Hyperphosphatemia
- Mita Seiji
- 2023-01-22
Completed
- A Phase 2a Study Assessing the Efficacy and Safety of STN1010905 Ophthalmic Suspension in Subjects with MGD
- MGD (Meibomian Gland Dysfunction)
- Migita Yukie
- 2021-10-08
Completed
- A phase 2a study of S-637880 in patients with neuropathic low back pain
- Neuropathic low back pain
- Nagata - Tsutae
- 2021-03-12
Completed
- A phase 2a study of TAS5315 in patients with chronic spontaneous urticaria
- chronic spontaneous urticaria
- Ali Nasermoaddeli
- 2022-04-15
Completed
- A Phase 2b Multinational, Randomised, Double-blind, Parallel-group, 24-week Placebo-controlled Study With 28-week Extension to Investigate the Use of Benralizumab in Patients With Moderate to Severe Chronic Spontaneous Urticaria (ARROYO)
- Chronic Spontaneous Urticaria
- Yamaji Shigeyuki
- 2021-01-25
Completed
- A Phase 2b Randomised, Double-Blind, Placebo-Controlled, Multi-Centre, Dose-Ranging Study of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
- Chronic Kidney Disease
- Hibi Kazushige
- 2020-11-16